News

Fanconi Cancer Foundation Names Isis Sroka, PhD as CEO; Mark Quinlan Will Serve in Advisory Role Through a Transition Period

The Fanconi Cancer Foundation (FCF) is excited to announce that Dr. Isis Sroka has been named CEO effective August 1, 2024. She succeeds Mark Quinlan who served as Executive Director since 2017 and recently announced his departure. Quinlan will continue in an advisory role with FCF through a transition period.

Read More >